2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
14
Lymphoma, Non-Hodgkin
10
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
7
Arthritis, Rheumatoid
7
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, B-Cell
5
Lymphoma
5
Solid Tumors
4
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Colorectal Neoplasms
4
Ovarian Neoplasms
3
Lymphoma, Follicular
3
Leukemia
3
Hematologic Neoplasms
3
Cytokine Release Syndrome
3
Burkitt Lymphoma
3
Urinary Bladder Neoplasms
2
Respiratory Distress Syndrome
2
Pancreatic Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Mantle-Cell
2
Fallopian Tube Neoplasms
2
Craniopharyngioma
2
Carcinoma, Hepatocellular
2
Interventions
Infliximab
3
Fecal Microbiota Transplantation
3
vedolizumab
2
Prednisone
2
Methylprednisolone
2
LDP-02
2
Immunoglobulin G
2
Disulfides
2
CT-P13
2
tocilizumab
1
prednylidene
1
fish oil triglycerides
1
deltacortene
1
Standard of Care
1
Practice Guidelines as Topic
1
Methylprednisolone Hemisuccinate
1
Loperamide
1
Injections
1
Endoscopy
1
Diagnosis
1
Colonoscopy
1
Cell- and Tissue-Based Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colitis
×
tocilizumab
×
Clear all
NCT03601611
2020-04-21
COLAR
Herlev Hospital
Phase NA
Completed
20 enrolled